Request for regulatory guidance for cancer cachexia intervention trials

Journal of Cachexia, Sarcopenia and Muscle

Volumn 6, Issue 4, 2015, Pages 272-274

  Fearon, K C H ^a   Argiles, J M ^b   Baracos, V E ^c   Bernabei, R ^d   Coats, A J S ^e,f   Crawford, J ^g   Deutz, N E ^h   Doehner, W ⁱ   Evans, W J ^j,k   Ferrucci, L ^l   Garcia, J M ^m   Gralla, R J ⁿ   Jatoi, A ^o   Kalantar Zadeh, K ^p   Lainscak, M ^q   Morley, J E ^r   Muscaritoli, M ^s   Polkey, M I ^t   Rosano, G ^u   Rossi Fanelli, F ^s   Schols, A M ^v   Strasser, F ^w   Vellas, B ^x   von Haehling, S ^y   Anker, S D ^y   more..

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF ALBERTA   (Canada)

^d CATHOLIC UNIVERSITY   (Italy)

^e MONASH UNIVERSITY   (Australia)

^f UNIVERSITY OF WARWICK   (United Kingdom)

^g DUKE CANCER INSTITUTE   (United States)

^h TEXAS A AND M UNIVERSITY   (United States)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j KINEMED INC   (United States)

^k DUKE UNIVERSITY MEDICAL CENTER   (United States)

^l NATIONAL INSTITUTES OF HEALTH   (United States)

^m MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁿ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^o MAYO CLINIC   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q General Hospital Celje   (Slovenia)

^r SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s SAPIENZA UNIVERSITY OF ROME   (Italy)

^t IMPERIAL COLLEGE LONDON   (United Kingdom)

^u IRCCS SAN RAFFAELE PISANA   (Italy)

^v MAASTRICHT UNIVERSITY   (Netherlands)

^w CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^x TOULOUSE UNIVERSITY HOSPITAL   (France)

^y UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANAMORELIN; ANTINEOPLASTIC AGENT; ENOBOSARM;

CACHEXIA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DRUG SAFETY; EDITORIAL; FAT MASS; FOOD AND DRUG ADMINISTRATION; FOOD INTAKE; GRIP STRENGTH; HEALTH CARE PERSONNEL; HUMAN; INTERVENTION STUDY; KINESIOTHERAPY; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE STRENGTH; NEOPLASM; NUTRITION; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; QUALITY OF LIFE; SKELETAL MUSCLE; STUDY DESIGN;

EID: 84951560384     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1002/jcsm.12083     Document Type: Editorial

References (16)

1. von Haehling S, Anker SD. Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014. J Cachexia Sarcopenia Muscle 2014;5:261–263.
2. Morley JE, Anker SD, von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. J Cachexia Sarcopenia Muscle 2014;5:253–259.
3. von Haehling S, Anker SD. Treatment of cachexia: an overview of recent developments. Int J Cardiol 2015;184:736–742.
4. Crawford J, Dalton JT, Hancock ML, Johnston MA, Steiner M. Enobosarm, a selective androgen receptor modulator (SARM), increases lean body mass (LBM) in advanced non-small cell lung cancer patients in two pivotal, international Phase 3 trials. J Cachexia Sarcopenia Muscle 2014;5:35–78(Abstract).
5. https://clinicaltrials.gov/ct2/show/NCT01355497 (accessed 11/07/2015).
6. https://clinicaltrials.gov/ct2/show/NCT01355484 (accessed 11/07/2015)
7. Abernethy A, Temel J, Currow D, Gleich L, Friend J. Anamorelin HCl for the treatment of anorexia-cachexia in lung cancer: study design and baseline characteristics of patients in the phase III clinical trial ROMANA 2 (HT-ANAM-302). J Cachexia Sarcopenia Muscle 2013;4:295–343(Abstract).
8. Reed RL, Pearlmutter L, Yochum K, Meredith KE, Mooradian AD. The relationship between muscle mass and muscle strength in the elderly. J Am Geriatr Soc 1991;39:555–561.
9. Alizadehkhaiyat O, Hawkes DH, Kemp GJ, Howard A, Frostick SP. Muscle strength and its relationship with skeletal muscle mass indices as determined by segmental bio-impedance analysis. Eur J Appl Physiol 2014;114:177–185.
10. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188: e13–64.
11. Piepoli MF, Conraads V, Corrà U, Dickstein K, Francis DP, Jaarsma T, et al. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail 2011;13:347–357.
12. Wakabayashi H, Sakuma K. Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management. J Cachexia Sarcopenia Muscle 2014;5:269–277.
13. Rhee CM, Kalantar-Zadeh K. Resistance exercise: an effective strategy to reverse muscle wasting in hemodialysis patients? J Cachexia Sarcopenia Muscle 2014;5:177–180.
14. von Haehling S, Anker SD. Treatment of cachexia: an overview of recent developments. J AmMed Dir Assoc 2014;15:866–872.
15. Zafar SY, Currow DC, Cherny N, Strasser F, Fowler R, Abernethy AP. Consensus-based standards for best supportive care in clinical trials in advanced cancer. Lancet Oncol 2012;13:e77–82.
16. Pani L, Pecorelli S, Rosano G, Anker SD, Peracino A, Fregonese L, et al. Steps forward in regulatory pathways for acute and chronic heart failure. Eur J Heart Fail 2015;17:3–8.